| Name | Title | Contact Details |
|---|
STAT PADS is a Boise, ID-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Healthline Med, Inc is a Baldwin Park, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
National HME is accredited by HQAA for Hospice Medical Equipment Services, as well as Clinical Respiratory Services. * National HME provides equipment for hospice patients 24/7 at no additional cost to the hospice program. * National HME provides simplified billing allowing your program more time to devote to patient care while reducing the hassle of HME bill reconciliation. Most contracts offered to hospice programs promote all-inclusive packaging with minimal extra charges allowing you the peace of mind that comes with understanding the exact cost for HME. * National HME maintains a minimal amount of warehoused equipment to streamline and work efficiently in our distribution centers. With new contracts equipment will be purchased for your initial deliveries and start up. This will bring a sense of revitalization to your staff and patients, enhancing morale and improving referrals. * Our staff at National HME are specifically trained to understand the process of the hospice industry; including death and dying, dealing with emotional and difficult family situations while showing compassion and empathy. We have extensive competency requirements for every employee that works at National HME. * Training for the family and care givers is extensive including detailed written materials provided. * We utilize modern technology that allows for web based ordering, a paperless delivery system that provides real time delivery and better control of the assets of the company. In the near future, we expect our equipment to have RFID technology that will allow us to find misplaced items in facilities more efficiently.
Savoy Medical Supply Co Inc is a Hauppauge, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
At T2 Biosystems, we are united in our mission: to improve patient outcomes, lower mortality rates and reduce the cost of healthcare by helping medical professionals make targeted treatment decisions earlier. By leveraging the power of our innovative and proprietary T2 Magnetic Resonance (T2MR) platform, T2 Biosystems’ diagnostics are designed to provide faster, easier and more accurate results than traditional methodologies. T2 Biosystems is currently targeting a range of critically underserved healthcare conditions, focusing initially on those for which a rapid diagnosis will serve an important dual role – saving lives and reducing costs. Our T2Candida Panel tackles sepsis and is the first FDA-cleared diagnostic panel requiring no blood culture – delivering more accurate results in hours versus days. Other ongoing development efforts include bacterial and hemostasis panels, as well as a Lyme disease partnership with Canon Life Sciences. Over 100 studies published in peer-reviewed journals have featured T2MR technology in a breadth of applications, including the direct detection and measurement of targets in various sample types, such as whole blood, plasma, serum, saliva, sputum and urine. With limits of detection as low as 1 CFU/mL, we believe T2MR technology will drive the next generation of diagnostics.